JPRN-UMIN000001471招募中1 期
Comparison of ursodeoxycholic acid 900 mg/day and 1200 mg/day for chronic hepatitis C patients - Comparison of UDCA 900 mg/day and 1200 mg/day for chronic hepatitis C
Department of Gastroenterology, the University of Tokyo Hospital0 个研究点目标入组 40 人开始时间: 2008年12月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •decompensated cirrhosis under anti-viral therapy complete biliary obstruction pregnancy
研究者
相似试验
招募中
不适用
The effect of using ursodeoxycholic acid in incident of gallstone in laparoscopic sleeve gastrectomyMorbid obesity.Other obesityE66.8IRCT20200708048049N1Shahid Beheshti University of Medical Sciences100
招募中
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N16Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg tabletIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N30Tabriz University of Medical Sciences24
招募中
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIRCT20210519051345N25Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N47Tabriz University of Medical Sciences24